Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
MacroGenics, Inc. - Common Stock
(NQ:
MGNX
)
1.830
+0.030 (+1.67%)
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 26, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about MacroGenics, Inc. - Common Stock
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
MacroGenics (MGNX) Q4 2022 Earnings Call Transcript
↗
March 15, 2023
MGNX earnings call for the period ending December 31, 2022.
Via
The Motley Fool
Earnings Scheduled For March 15, 2023
↗
March 15, 2023
Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million.
Via
Benzinga
The Latest Analyst Ratings for Macrogenics
↗
January 19, 2023
Via
Benzinga
7 Analysts Have This to Say About Macrogenics
↗
November 23, 2022
Via
Benzinga
Expert Ratings for Macrogenics
↗
November 23, 2022
Via
Benzinga
What 7 Analyst Ratings Have To Say About Macrogenics
↗
November 23, 2022
Via
Benzinga
Illumina, Seagen And Other Big Stocks Moving Higher On Monday
↗
March 13, 2023
U.S. stocks traded slightly lower, with the Nasdaq Composite dropping around 0.2% on Monday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Why Shares of MacroGenics Jumped Thursday
↗
March 09, 2023
The company made a sale worth as much as $200 million for the royalty rights for its type-1 diabetes therapy.
Via
The Motley Fool
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
March 09, 2023
Via
Benzinga
General Electric, Build-A-Bear Workshop, Asana And Other Big Stocks Moving Higher On Thursday
↗
March 09, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 50 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Where Macrogenics Stands With Analysts
↗
November 23, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
March 09, 2023
Via
Benzinga
MacroGenics Announces Sale of TZIELD™ Royalty Interest for up to $200 Million
March 08, 2023
From
MacroGenics, Inc.
Via
GlobeNewswire
MacroGenics Announces Date of Fourth Quarter 2022 Financial Results Conference Call
March 07, 2023
From
MacroGenics, Inc.
Via
GlobeNewswire
MacroGenics to Participate in Upcoming Investor Conferences
March 02, 2023
From
MacroGenics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
↗
February 20, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
February 17, 2023
Via
Benzinga
AutoNation, HubSpot, AMC Networks And Other Big Stocks Moving Higher On Friday
↗
February 17, 2023
U.S. stocks traded lower, with the Nasdaq Composite dropping over 100 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Around $11M Bet On Insight Enterprises? Check Out These 4 Stocks Insiders Are Buying
↗
February 17, 2023
Although US stocks closed lower on Thursday, there were a few notable insider trades.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
February 14, 2023
Via
Benzinga
MacroGenics Posts Interim Data From Lorigerlimab Study In Prostate Cancer Patients
↗
February 14, 2023
Via
Benzinga
MacroGenics Announces Preliminary Clinical Results from Single Arm Study of Lorigerlimab in Patients with Metastatic Castration-Resistant Prostate Cancer to be Presented at ASCO Genitourinary Cancers Symposium
February 13, 2023
From
MacroGenics, Inc.
Via
GlobeNewswire
MacroGenics to Participate in Upcoming Investor Conferences
February 06, 2023
From
MacroGenics, Inc.
Via
GlobeNewswire
Tesla To Rally Around 138%? Here Are 10 Other Analyst Forecasts For Thursday
↗
January 19, 2023
JP Morgan cut the price target for Apple Inc. (NASDAQ: AAPL) from $190 to $180. JP Morgan analyst Samik Chatterjee maintained an Overweight rating. Apple shares fell 1.1% to $133.70 in pre-market...
Via
Benzinga
MacroGenics to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 04, 2023
From
MacroGenics, Inc.
Via
GlobeNewswire
MacroGenics Announces Appointment of Dr. Margaret Liu and Meenu Chhabra Karson to Board of Directors
January 04, 2023
From
MacroGenics, Inc.
Via
GlobeNewswire
$5 Million Bet On IAC? Check Out These 3 Stocks Insiders Are Buying
↗
November 28, 2022
Although US stocks closed mixed on Friday, there were a few notable insider trades.
Via
Benzinga
Baidu To $180? Plus This Analyst Cuts PT On MacroGenics By 56%
↗
November 23, 2022
Mizuho cut the price target on Baidu, Inc. (NASDAQ: BIDU) from $200 to $180. Mizuho analyst James Lee maintained the stock with a Buy rating. Baidu shares rose 2.5% to trade at $97.49 on Wednesday.
Via
Benzinga
Burlington Stores To Surge Over 21%? Plus Wedbush Slashes PT On Jack In The Box
↗
November 23, 2022
Barclays raised the price target on Burlington Stores, Inc. (NYSE: BURL) from $164 to $230. Barclays analyst Adrienne Yih maintained an Overweight rating on the stock. Burlington shares fell 0.1% to...
Via
Benzinga
See Why Gilead's Cancer Business Is Driving The Stock To A Fever Pitch
↗
November 23, 2022
Sales accelerated, again, in the third quarter. Here's what the company and analysts are watching.
Via
Investor's Business Daily
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
